Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study
Tóm tắt
One in four Swedish women suffers a hip fracture yielding high morbidity and mortality. We wanted to revalidate a 4-item clinical risk score and evaluate a portable heel bone mineral density (BMD) technique regarding hip and fragility fracture risk among elderly women. In a population-based prospective cohort study we used clinical risk factors from a baseline questionnaire and heel BMD to predict a two-year hip and fragility fracture outcome for women, in a fracture preventive program. Calcaneal heel BMD was measured by portable dual X-ray laser absorptiometry (DXL) and compared to hip BMD, measured with stationary dual X-ray absorptiometry (DXA) technique. Seven women suffered hip fracture and 14 women fragility fracture/s (at hip, radius, humerus and pelvis) among 285 women; 60% having heel BMD ≤ -2.5 SD. The 4-item FRAMO (Fracture and Mortality) Index combined the clinical risk factors age ≥80 years, weight <60 kg, prior fragility fracture, and impaired rise-up ability. Women having 2-4 risk factors showed odds ratio (OR) for hip fracture of 5.9 and fragility fracture of 4.4. High risk group hip fracture risk was 2.8% annually compared to 0.5% for the low risk majority (69%). Heel BMD showed hip fracture OR of 3.1 and fragility fracture OR of 2.6 per SD decrease. For 30 DXA assessed participants mean hip BMD at -2.5 SD level corresponded to a lower BMD at the heel. Five of seven hip fractures occurred within a small risk group of 32 women, identified by high FRAMO Index + prior fragility fracture + heel T-score ≤-3.5 SD. In a follow-up study we identified high risk groups for hip and fragility fracture with our plain 4-item risk model. Increased fracture risk was also related to decreasing heel BMD in calcaneal bone, measured with a mobile DXL technique. A combination of high FRAMO Index, prior fragility fracture, and very low BMD restricted the high risk group to 11%, among whom most hip fractures occurred (71%). These practical screening methods could eventually reduce hip fracture incidence by concentrating preventive resources to high fracture risk women.
Tài liệu tham khảo
Kanis JA: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994, 4 (6): 368-381. 10.1007/BF01622200.
Sernbo I, Johnell O: Consequences of a hip fracture: a prospective study over 1 year. Osteoporos Int. 1993, 3 (3): 148-153. 10.1007/BF01623276.
Kanis JA, Johnell O, Oden A, Jonsson B, Dawson A, Dere W: Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int. 2000, 11 (2): 120-127. 10.1007/PL00004173.
Fuller GF: Falls in the elderly. Am Fam Physician. 2000, 61 (7): 2159-2168. 2173-2154
Feskanich D, Willett W, Colditz G: Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002, 288 (18): 2300-2306. 10.1001/jama.288.18.2300.
Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM: Falls prevention over 2 years: a randomized controlled trial in women 80 years and older. Age Ageing. 1999, 28 (6): 513-518. 10.1093/ageing/28.6.513.
Day L, Fildes B, Gordon I, Fitzharris M, Flamer H, Lord S: Randomised factorial trial of falls prevention among older people living in their own homes. BMJ. 2002, 325 (7356): 128-10.1136/bmj.325.7356.128.
Buchner DM, Cress ME, de Lateur BJ, Esselman PC, Margherita AJ, Price R, Wagner EH: The effect of strength and endurance training on gait, balance, fall risk, and health services use in community-living older adults. J Gerontol A Biol Sci Med Sci. 1997, 52 (4): M218-224.
Hoidrup S, Prescott E, Sorensen TI, Gottschau A, Lauritzen JB, Schroll M, Gronbaek M: Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol. 2000, 29 (2): 253-259. 10.1093/ije/29.2.253.
Cumming RG, Thomas M, Szonyi G, Salkeld G, O'Neill E, Westbury C, Frampton G: Home visits by an occupational therapist for assessment and modification of environmental hazards: a randomized trial of falls prevention. J Am Geriatr Soc. 1999, 47 (12): 1397-1402.
Gillespie L, Gillespie W, Robertson M, Lamb S, Cumming R, Rowe B: Interventions for preventing falls in elderly people. Cochrane Database Syst Rev. 2003, 4: CD000340-
Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM: Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 1999, 47 (7): 850-853.
Bischoff-Ferrari HA, Dawson-Huges B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB: Effect of Vitamin D on Falls: A Meta-analysis.[Review]. Jama. 2004, 291 (16): 1999-2006. 10.1001/jama.291.16.1999.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992, 327 (23): 1637-1642.
Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003, 326 (7387): 469-10.1136/bmj.326.7387.469.
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A: Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007, 370 (9588): 657-666. 10.1016/S0140-6736(07)61342-7.
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B: Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005, 293 (18): 2257-2264. 10.1001/jama.293.18.2257.
Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL: Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2005, CD000227-3
Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, Thompson DE, Karpf DB: Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med. 1997, 157 (22): 2617-2624. 10.1001/archinte.157.22.2617.
Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D: Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005, 20 (6): 971-976. 10.1359/JBMR.050104.
Wilkins CH, Birge SJ: Prevention of osteoporotic fractures in the elderly. Am J Med. 2005, 118 (11): 1190-1195. 10.1016/j.amjmed.2005.06.046.
Lauritzen JB, Petersen MM, Lund B: Effect of external hip protectors on hip fractures. Lancet. 1993, 341 (8836): 11-13. 10.1016/0140-6736(93)92480-H.
Meyer G, Warnke A, Bender R, Muhlhauser I: Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial. Bmj. 2003, 326 (7380): 76-10.1136/bmj.326.7380.76.
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM: Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995, 332 (12): 767-773. 10.1056/NEJM199503233321202.
De Laet CE, van Hout BA, Burger H, Hofman A, Pols HA: Bone density and risk of hip fracture in men and women: cross sectional analysis. Bmj. 1997, 315 (7102): 221-225.
Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A: A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004, 35 (2): 375-382. 10.1016/j.bone.2004.03.024.
Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner WS, Nevitt MC, Cummings SR: BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003, 18 (11): 1947-1954. 10.1359/jbmr.2003.18.11.1947.
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E: FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008, 19 (4): 385-397. 10.1007/s00198-007-0543-5.
Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O: An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001, 12 (7): 519-528. 10.1007/s001980170072.
Kanis JA: Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002, 359 (9321): 1929-1936. 10.1016/S0140-6736(02)08761-5.
Marshall D, Johnell O, Wedel H: Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Bmj. 1996, 312 (7041): 1254-1259.
Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Chen YT, Berger ML, Santora AC, Sherwood LM: Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res. 2002, 17 (12): 2222-2230. 10.1359/jbmr.2002.17.12.2222.
Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N: Assessment of fracture risk. Osteoporos Int. 2005, 16 (6): 581-589. 10.1007/s00198-004-1780-5.
Melton LJ: How many women have osteoporosis now?. J Bone Miner Res. 1995, 10 (2): 175-177. 10.1002/jbmr.5650100202.
Albertsson DM, Mellstrom D, Petersson C, Eggertsen R: Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Ann Fam Med. 2007, 5 (1): 48-56. 10.1370/afm.602.
Albertsson D, Mellstrom D, Petersson C, Eggertsen R: The 4-item Fracture and Mortality Index predictied hip fracture and all cause mortality in elderly women. Abstraction of the BMJ Publishing Group, Gill Sudeep commentator. Evidense-Based Medicine. 2007, 12 (4): 122-10.1136/ebm.12.4.122.
Kullenberg R, Falch JA: Prevalence of osteoporosis using bone mineral measurements at the calcaneus by dual X-ray and laser (DXL). Osteoporos Int. 2003, 14 (10): 823-827. 10.1007/s00198-003-1442-z.
Kullenberg R: Reference database for dual X-ray and laser Calscan bone densitometer. J Clin Densitom. 2003, 6 (4): 367-372. 10.1385/JCD:6:4:367.
Albertsson D: Hip fracture prevention by screening and intervention of elderly women in Primary Health Care. Thesis Göteborg university. 2007
Swanpalmer J, Kullenberg R: A new measuring device for quantifying the amount of mineral in the heel bone. Ann N Y Acad Sci. 2000, 904: 115-117.
Hakulinen MA, Saarakkala S, Toyras J, Kroger H, Jurvelin JS: Dual energy x-ray laser measurement of calcaneal bone mineral density. Phys Med Biol. 2003, 48 (12): 1741-1752. 10.1088/0031-9155/48/12/305.
Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C: Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res. 1994, 9 (10): 1503-1514. 10.1002/jbmr.5650091002.
Altman D: Practical statistics for medical research. 1991, Chapman & Hall/CRC, London, 399-400.
Paganini-Hill A, Chao A, Ross RK, Henderson BE: Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology. 1991, 2 (1): 16-25.
Albrand G, Munoz F, Sornay-Rendu E, DuBoeuf F, Delmas PD: Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. Bone. 2003, 32 (1): 78-85. 10.1016/S8756-3282(02)00919-5.
Salminen H, Saaf M, Ringertz H, Strender LE: Bone mineral density measurement in the calcaneus with DXL: comparison with hip and spine measurements in a cross-sectional study of an elderly female population. Osteoporos Int. 2005, 16 (5): 541-551. 10.1007/s00198-004-1719-x.
Blake GM, Chinn DJ, Steel SA, Patel R, Panayiotou E, Thorpe J, Fordham JN: A list of device-specific thresholds for the clinical interpretation of peripheral x-ray absorptiometry examinations. Osteoporos Int. 2005, 16 (12): 2149-2156. 10.1007/s00198-005-2018-x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/11/55/prepub